(December 8, 2023, 3:26 PM EST) -- WASHINGTON, D.C. — Attorneys representing nine individuals who allege that they suffered gastrointestinal and other injuries from diabetes and diet drugs such as Ozempic, Wegovy and Mounjaro have asked the U.S. Judicial Panel for Multidistrict Litigation (JPMDL) to transfer all currently filed and any subsequently filed cases and centralize them in the U.S. District Court for the Western District of Louisiana....